News Headlines Article

Senators voice interest in Medicare Part D, Part B reforms
Modern Healthcare

The Senate Finance Committee on Tuesday signaled interest in bolstering key points in the Trump administration’s drug-pricing blueprint, including potential structural reforms for Medicare Part B and Part D.Senators from both sides of the aisle waded into a proposal highly unpopular with physicians and hospitals, aimed at removing the incentive for providers who administer drugs under Medicare Part B to prescribe the most expensive option. HHS Secretary Alex Azar has proposed giving providers a flat fee for the drugs, rather than the current system of the average sales price of the drug plus 4.3%.